Schedule 18 : Employee Benefits
 
 In accordance with Accounting Standard 15 Employee Benefts, the
 Company has classified various benefits provided to employees as under:
 
 I Defined Contribution Plans
 
 a.  Provident Fund*
 
 b.  Superannuation Fund
 
 c.  State Defined Contribution Plans
 
 i.  Employers Contribution to Employees State Insurance
 
 ii.  Employers Contribution to Employees Pension Scheme 1995
 
 * The Guidance on Implementing AS 15, Employee Benefits issued by the
 Accounting Standards Board (ASB) states benefit involving employer
 established provident funds, which require interest shortfall to be
 recompensed are to be considered as defined benefit plans. Pending the
 issuance of the guidance note from the Actuarial Society of India, the
 Companys actuary has expressed an inability to reliably measure
 provident fund liabilities. Accordingly, the Company is unable to
 exhibit the related information.
 
 III Other Employee Benefit Plan
 
 The liability for leave encashment as at the year end is Rs. 12,41.69
 Lacs (Previous Year : Rs. 8,73.92 Lacs).  Included in Provisions (Refer
 Schedule 12).
 
 Schedule 19 : Segment Information
 
 In accordance with the requirements of Accounting Standard-17 Segment
 Reporting, the Companys Business Segment is Personal Care (including
 Oral Care) and hence it has no other primary reportable segments.  Non
 Reportable Segment has been disclosed as unallocated reconciling item.
 Segment revenue and Segment expenses have been accounted on the basis
 of their relationship to the operating activities of the Company.
 Assets and liabilities which relate to the enterprise as a whole and
 are not allocable to the segment on a reasonable basis have been
 included under unallocated assets/liabilities. Revenue and expenses
 pertaining to non reportable segment have been disclosed as unallocated
 results.
 
 Schedule 20 : Disclosure of Related Parties
 
 Related Party Disclosures, as required by Accounting Standard-18,
 Related Party Disclosures, are given below:
 
 i) Ultimate Holding Company : Colgate-Palmolive Company, U.S.A.
 
 ii) Subsidiaries            : CC Healthcare Products Private Limited
 
                               (Merged with the Company during the 
                               year with appointed date April 1, 2009)
 
 iii) Group Companies where  : Colgate-Palmolive (Malaysia) Mktg. 
                               SDN BHD
 common control exists       : Colgate-Palmolive, East Africa Ltd., 
                               Kenya
 
                             : Colgate-Palmolive, Marocco Limited
 
                             : Colgate-Palmolive Pty Ltd., South Africa
 
                             : Colgate-Palmolive Pty Ltd., Australia
 
                             : Colgate-Palmolive (Thailand) Ltd.
 
                             : Colgate-Palmolive (H.K.) Ltd., Hong Kong
 
                             : Colgate-Palmolive Management Services 
                               (H.K.) Limited
 
                             : Colgate-Palmolive (China) Co. Ltd., China
                               (formerly known as Colgate-Palmolive 
                               (Guangzhou) Co. Ltd., China)
 
                             : Colgate-Palmolive Son Hai Ltd., Vietnam
 
                             : Colgate Sanxiao (Consumer Products)  
                               Company Limited
 
                             : Hawley & Hazel Chemical Company (H.K.) 
                               Limited
 
                             : Colgate-Palmolive, Temizlik, Urunleri, 
                               Turkey
 
                             : Colgate-Palmolive Romania srl.
 
                             : Colgate-Palmolive (Eastern) Pte. Ltd., 
                               Singapore
 
                             : Colgate-Palmolive Industria E Commercio 
                               Ldta, Brazil
 
                             : Colgate-Palmolive (Asia) Pte. Ltd. 
                               Singapore
 
                             : Colgate-Palmolive Tanzania Limited
 
                             : CP Hawley & Hazel Chemical Co., (ZS) 
                               Ltd.
 
                             : Colgate-Palmolive Zambia Inc.
 
                             : Colgate-Palmolive Services Poland
 
                             : Colgate-Palmolive (PNG) Limited, PNG
 
                             : Hills Pet Nutrition, Inc., Topeka
 
                             : Hills Pet Nutrition Manufacturing, 
                               s. r. o.
 
                             : Colgate-Palmolive Bt Ltd., Blantyre, 
                               Malawi
 
                             : Colgate Oral Pharmaceuticals, Inc. 
                               Carrollton, U.S.A.
 
                             : Colgate-Palmolive CACE Region, 
                               Istanbul, Turkey
 
                             : Colgate-Palmolive (Fiji) Ltd.
 
                             : Colgate-Palmolive Senegal
 
 iv) Key Management Personnel : Roger Calmeyer (Upto January 31, 
                                2010)
 
                             : Mukul Deoras (Effective February 
                               1, 2010)
 
                             : Moses Elias (Upto November 30, 2010)
 
                             : K. V. Vaidyanathan
 
                             : Paul E. Alton (Effective September 
                               1, 2010)
 
 v) Relatives of Key
 Management Personnel        : Mrs. Pratima Elias (Upto November 
                               30, 2010)
 
 Schedule 23 : Contingencies and Commitments
 
 2.  Contingent liabilities not provided for in respect of: 
 
 (Refer Note 6 on Schedule 17)
 
 (i) Guarantees given by the Company            9,30.00    7,82.00
 
 (ii) Counter Guarantees given to the Banks     4,06.47    3,34.45
 
 (iii) Cheques Discounted with Banks              25.23      85.42
 
 (iv) Claims against the Company not 
     acknowledged as debts                      1,55.41    1,55.20
 
 (v) Excise and Related Matters                41,91.42   19,94.30
 
 (vi) Service Tax Matters                       5,30.49   12,49.56
 
 (vii) Income Tax Matters                       3,10.93    2,22.26
 
 (viii) Provident Fund Matters                     7.37       7.37
 
 
 Note :
 
 Future cash flow in respect of (iv) to (viii) above, if any, is
 determinable only on receipt of judgements/decisions pending with the
 relevant authorities.
 
 Schedule 24 : Others/Contingencies
 
 Note :
 
 Direct/Indirect Taxes
 
 Represents estimates made for probable liabilities arising out of
 pending disputes/litigations with various tax authorities. The timing
 of the outflow with regard to the said matter depends on the exhaustion
 of remedies available to the Company under the law and hence the
 Company is not able to reasonably ascertain the timing of the outflow.
 
 Schedule 25 : Supplementary Information
 
 Notes :
 
 (i) In terms of the Industrial Entrepreneurs Memoranda filed with the
 Government of India, Ministry of Commerce and Industry, New Delhi, the
 aggregate registered annual capacity of toothpaste and toothpowder at
 Baddi, Goa, Hyderabad and Aurangabad is 165,475 tonnes (Previous Year:
 165,475 tonnes) and flavour is 6,675 tonnes (Previous Year: 4,475
 tonnes). The annual capacities of the erstwhile Professional Oral Care
 Products Private Limited (POC) engaged in the manufacture of toothpaste
 at Goa and CC Healthcare Products Private Limited (CCHL) engaged in the
 manufacture of toothpowder at Hyderabad have been included in the said
 annual capacity of 165,475 tonnes following merger of POC and CCHL with
 the Company from April 1, 2009 in terms of the Orders issued by the
 Bombay High Court at Goa and Andhra Pradesh High Court sanctioning the
 respective schemes of Amalgamation of POC and CCHL with the Company.
 
 (ii) The bristling operations for toothbrushes and shave brushes are
 carried out under manufacturing arrangements with third parties.
 
 (iii) The installed capacity as shown above have been certified by the
 Executive Vice-President (Manufacturing and Product Supply Chain) and
 not verified by the Auditors, being a technical matter.
 
 8. There are no delays in payments to Micro and Small enterprises as
 required to be disclosed under the Micro, Small and Medium Enterprises
 Development Act, 2006. The information regarding Micro and Small
 enterprises has been determined to the extent such parties have been
 identified on the basis of information available with the Company. This
 has been relied upon by the Auditors.
 
 Note :
 
 Approval for appointment of Mr. Paul E. Alton as the Whole-time Finance
 Director & Chief Financial Officer of the Company effective September
 1, 2010, will be sought at the ensuing Annual General Meeting. During
 the year, an aggregate remuneration of Rs. 2,66.03 Lacs has been paid
 to him.
 
 10.  The amount of excise duty disclosed as deduction from turnover is
 the total excise duty for the year except the excise duty related to
 the difference between the closing stock and opening stock and excise
 duty paid but not recovered, which has been disclosed as excise duty
 expense in Cost of Goods Sold - Increase/ (Decrease) in Excise Duty on
 Finished Goods under Schedule 14 annexed and forming part of Profit
 and Loss Account.
 
 11.  Research and Development expenses of the year for the Company
 amount to Rs. 4,32.71 Lacs (Previous Year: Rs. 2,97.28 Lacs).
 
 12. (a) Pursuant to the Scheme of Amalgamation (the Scheme)
 sanctioned by the order dated August 11, 2010 of the High Court of
 Judicature at Andhra Pradesh, CC Healthcare Products Private Limited
 (CCH), 100% subsidiary of the Company, engaged in the business of
 manufacturing of tooth powder, has been amalgamated with the Company
 with effect from April 1, 2009. The amalgamation has been accounted as
 per the Scheme which is in accordance with the Pooling of Interests
 method as prescribed by Accounting Standard (AS-14), Accounting for
 Amalgamations.
 
 In accordance with the said Scheme :
 
 a) the assets and liabilities of CCH have been taken over by the
 Company with effect from April 1, 2009 and have been recorded at their
 respective book values.
 
 b) General Reserve and Profit and Loss Balance aggregating Rs. 2,56.27
 Lacs as on April 1, 2009 of CCH has been transferred to General Reserve
 of the Company.
 
 c) 2,00,000 Equity Shares of Rs. 10 each fully paid in CCH held as an
 investment by the Company stands cancelled. The deficit of Rs. 1,52.89
 Lacs between the net assets and reserves taken over from CCH and the
 book value of investment held by the Company in CCH, after adjustment
 of dividend payable by CCH, have been adjusted to General Reserve.
 
 13. During the previous year, pursuant to the Scheme of Amalgamation
 (the Scheme) sanctioned by the order dated April 16, 2010 of Bombay
 High Court at Goa, Professional Oral Care Products Private Limited
 (POC), 100% subsidiary of the Company, engaged in the business of
 manufacturing of toothpaste, was amalgamated with the Company with
 effect from April 1, 2009. The amalgamation has been accounted as per
 the Scheme which is in accordance with the Pooling of Interests
 method as prescribed by Accounting Standard (AS-14), Accounting for
 Amalgamations.
 
 In accordance with the said Scheme :
 
 i) the assets and liabilities of POC have been taken over by the
 Company with effect from April 1, 2009 and have been recorded at their
 respective book values.
 
 ii) Capital Reserve of Rs. 2,24.96 Lacs and General Reserve and Profit
 and Loss Balance aggregating Rs. 6,15.62 Lacs of POC as on April 1,
 2009 has been transferred to Capital Reserve and General Reserve of the
 Company, respectively.
 
 iii) 12,01,200 Equity Shares of Rs. 10 each fully paid in POC held as
 an investment by the Company stands cancelled. The deficit of Rs.
 4,02.57 Lacs between the net assets and reserves taken over from POC
 and the book value of investment held by the Company in POC, after
 adjustment of dividend payable by POC, have been adjusted to Capital
 Reserve by Rs. 2,51.46 Lacs and the balance deficit has been adjusted
 to General Reserve.
 
 14.  Current Tax is net of prior year reversals of Fringe Benefit Tax
 of Rs. 7,49.02 Lacs (Previous Year: Rs. Nil).
 
 15.  In view of the Scheme of Amalgamation referred to in Note 12
 above, the current year figures are not comparable with those of the
 previous year.
 
 16.  Refer Annexure for additional information pursuant to Part IV of
 Schedule VI to the Companies Act, 1956.
 
 17.  Previous years figures have been re-grouped and re-arranged
 wherever necessary.
 
 The Schedules (1 to 25) referred to herein above form an integral part
 of the financial statements.